[1]
E. K. de A. Silva, E. I. Rabito, and C. Queiroz, “The use of bioactive compounds in the modulation of adverse effects of antineoplastic treatment”, Rev. Uningá, vol. 59, p. eUJ4061, Mar. 2022.